HELP US KEEP REPORTING. DONATE TO ORLANDO WEEKLY PRESS CLUB.

This is your Congress on drugs 


Whether on toothpaste or breakfast cereal, you can bet that when a "New and Improved!" label appears on a package, it means you'll pay more and get less.

Congress has learned this art of deceptive packaging, too. Hence, Newt Gingrich's 1995 proposal for a new tax giveaway to the privileged was labeled the "Job Creation Act." Likewise comes the "FDA Modernization Act of 1997" -- a twisted bit of legislation that "modernizes" the Food & Drug Administration's consumer-protection regulations like a tornado modernizes a trailer park.

This bill was not even written by a member of Congress. Instead, it's primarily the product of lobbyists for the giant manufacturers of drugs and medical devices. The industry put up $34 million in campaign contributions and, in turn, the Republican leadership of Congress allowed the lobbyists to "modernize" the laws regulating their own industry. No consumers were allowed to participate in this rewrite and no public hearings were held. The Health Research Group of Public Citizen, a consumer-watchdog organization, looked into it and found these uglies written into the new law:

Instead of the FDA reviewing safety claims of a medical device, now the manufacturer can select and hire its own private tester -- a brother-in-law deal if I ever saw one!

It used to be that at least two clinical investigations were necessary to OK a drug's effectiveness and safety; now, only one is required.

The rewrite also says that keeping track of the performance of heart valves and other high-risk medical devices is optional, rather than mandatory.

Finally, the new law tilts the regulatory process itself against us consumers and patients.

To learn more about this regulatory gut job, call Public Citizen's Health Research Group: (202) 588-1000.


We welcome readers to submit letters regarding articles and content in Orlando Weekly. Letters should be a minimum of 150 words, refer to content that has appeared on Orlando Weekly, and must include the writer's full name, address, and phone number for verification purposes. No attachments will be considered. Writers of letters selected for publication will be notified via email. Letters may be edited and shortened for space.

Email us at feedback@orlandoweekly.com.

Orlando Weekly works for you, and your support is essential.

Our small but mighty local team works tirelessly to bring you high-quality, uncensored news and cultural coverage of Central Florida.

Unlike many newspapers, ours is free – and we'd like to keep it that way, because we believe, now more than ever, everyone deserves access to accurate, independent coverage of their community.

Whether it's a one-time acknowledgement of this article or an ongoing pledge, your support helps keep Orlando’s true free press free.

Speaking of Jim Hightower

More by Jim Hightower

Newsletters

Never miss a beat

Sign Up Now

Subscribe now to get the latest news delivered right to your inbox.

Read the Digital Print Issue

October 21, 2020

View more issues

Calendar

© 2020 Orlando Weekly

Website powered by Foundation